KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Times Interest Earned (2016 - 2025)

Novavax has reported Times Interest Earned over the past 16 years, most recently at $2.44 for Q4 2025.

  • Quarterly results put Times Interest Earned at $2.44 for Q4 2025, up 114.14% from a year ago — trailing twelve months through Dec 2025 was $20.08 (up 261.95% YoY), and the annual figure for FY2025 was $20.08, up 261.95%.
  • Times Interest Earned for Q4 2025 was $2.44 at Novavax, up from -$32.47 in the prior quarter.
  • Over the last five years, Times Interest Earned for NVAX hit a ceiling of $90.08 in Q1 2025 and a floor of -$160.56 in Q4 2021.
  • Median Times Interest Earned over the past 5 years was -$33.85 (2024), compared with a mean of -$27.46.
  • Biggest five-year swings in Times Interest Earned: plummeted 1058.13% in 2021 and later soared 355.68% in 2025.
  • Novavax's Times Interest Earned stood at -$160.56 in 2021, then surged by 66.99% to -$53.01 in 2022, then rose by 15.88% to -$44.59 in 2023, then skyrocketed by 61.24% to -$17.28 in 2024, then surged by 114.14% to $2.44 in 2025.
  • The last three reported values for Times Interest Earned were $2.44 (Q4 2025), -$32.47 (Q3 2025), and $18.32 (Q2 2025) per Business Quant data.